Choledochal Cyst and Gallbladder Disease Flashcards
What is the appropriate surgical repair for the most common type of choledochal cyst?
A. Hepaticojejunostomy
B. Choledochojejunostomy
C. Cyst resection alone
D. Observation only
E. Cholecystectomy
ANSWER: A
COMMENTS: Although it is possible to diagnose choledochal cysts in utero, more often they present by the age of 10 with right upper quadrant pain, jaundice, and occasionally a palpable mass.
Ultrasound is the appropriate first diagnostic step, examining both the intra- and extrahepatic biliary systems.
When there is a concern for biliary atresia versus a cyst, a HIDA scan can be performed to delineate the anatomy.
There are five major types of choledochal cysts:
Type I is the most common, representing about 90% of cases. This is a fusiform dilatation of the common bile duct but does not involve the intrahepatic biliary system. Surgical management of type I cysts includes resection of the affected portion of the common bile duct with a hepaticojejunostomy and Roux-en- Y limb.
Type II cysts are a diverticulum off of the side of the common bile duct, and there is no intra- or extrahepatic ductal dilation. This is managed with a simple cyst resection. Often, this may be done laparoscopically.
A type III cyst is dilatation of the very distal common bile duct and is usually either intrapancreatic or intraduodenal. These cysts are also known as choledochoceles. There is no dilatation of the proximal common bile duct or intra- hepatic ducts. These cysts may be managed with either marsupialization or with endoscopic retrograde cholangiopancreatography (ERCP) and sphincterotomy.
A type IV disease is defined as multiple cysts that may be intrahepatic, extrahepatic, or both. It is recommended that the common bile duct cyst be resected up to the hepatic ducts with a hepaticojejunostomy and Roux-en-Y limb.
Type V, also known as Caroli disease, is multiple exclusively intrahepatic biliary cysts. The operative management of this disease is not straightforward and ranges from segmental resection to liver transplantation. Cyst excision is advocated not only to avoid a biliary obstruction leading to pancreatitis and cholangitis but also to reduce the risk of malignancy.
Types I, IV, and V cysts have the highest malignant potential. This risk of malignant transformation increases with incomplete cyst excision as well as older age at the time of resection.
Discuss choledochal cysts.
Choledochal cysts are congenital, cystic dilatations of the biliary tree that can occur with an incidence of approximately 1:100,000–1:150,000 in the Western hemisphere and a reported incidence of 1:1,000 in the Asian population.
The majority of patients with choledochal cysts remain asymptomatic and diagnosis is made due to an incidental finding.
Only a minority presents with clinical signs of jaundice/obstruction, cholangitis/pancreatitis, or an acute abdomen due to secondary complications.
Diagnostics include abdominal ultrasound and blood tests, an MRCP can further specify the anatomy if necessary and in cases of acute obstruction an ERCP with stenting is required.
Choledochal cysts are premalignant conditions; therefore, the therapy consists of a complete choledochal cyst excision, early after diagnosis.
This can be performed using “open” or “laparoscopic” surgery.
The reconstruction afterwards includes a biliodigestive anastomosis, which can be either a hepatico-jejunostomy with a Roux-en-Y loop, or a hepatico-duodenostomy.
Currently, there is no evidence for the superiority of any of these techniques.
After choledochal cyst excision the lifetime risk for malignancies is reduced, but recent data suggest a lifelong elevated risk of up to 11% of cancer development even following operation.
Therefore, lifelong follow-ups are necessary.
What are choledochal cysts?
Choledochal cysts are rare congenital, cystic dilatations of the biliary tree that can occur anywhere between the duodenum and the intrahepatic bile ducts [1].
The etiology of this condition is still unknown.
The first anatomical description was made in 1723 by the German anatomist and botanist Abraham Vater (1684–1751), who is also known for the ampulla of Vater and Lamellar corpuscles. Golder Lewis McWhorter (1888–1938) was the first surgeon to report on the surgical “cure” of a 49-year-old lady with choledochal cyst at the Presbyterian Hospital in Chicago/ USA in 1924.
What is the common classification for choledochal cysts?
Todani classification. It was introduced in 1977 by Takuji Todani at the Department of Surgery/University Medical School in Okayama, Japan. Since then it has been modified, including information on the location and appearance of the choledochal dilatation (e.g. isolated or disseminated cysts) [Lee et al., Korean J Radiol. 2009 Jan-Feb;10(1):71–80)].
Type I: saccular/diffuse fusiform dilatation of common bile duct, typically inferior to the confluence of the left and right hepatic ducts (the most common type)
Type II: diverticulum of the common bile duct
Type III: intraduodenal dilatation of the common bile duct
Type IV: multiple cysts of the intra- or extrahepatic bile ducts (or both)
Type V: single or multiple intrahepatic cysts
What is the common channel?
The common channel describes the unification of the common bile duct and the pancreatic duct.
In the majority of choledochal cysts, this unification already appears outside the duodenal wall, called pancreatobiliary maljunction and leading to a “long” common channel [Kamisawa T et al. (2017), J Gastroenterol., Feb;52(2):158–163].
What are “forme fruste choledochal cysts”?
The term “forme fruste” was introduced by John R Lilly of the Children’s Hospital Denver in 1985, describing a stenosis of the distal common bile duct of unknown origin, with a “long common channel” and classical histopathological features of choledochal cysts (in the common bile duct wall).
In the majority of cases the minimal (or nonexistent) dilatation of the extrahepatic bile duct and the pancreaticobiliary maljunction are present at first admission, without signs of stones, tumor, or inflammation.
How common are choledochal cysts?
The incidence of choledochal cysts is approximately 1:100,000–1:150,000 in the Western hemisphere, with high geographical variations and a reported incidence of 1:1,000 in the Asian population.
While the majority is diagnosed during childhood, in some patients the diagnosis is delayed until adulthood.
Higher numbers are expected, due to the fact that many patients remain undiagnosed during their lifetime.
How do patients with choledochal cysts usually present?
The majority of patients with choledochal cysts remain asymptomatic and diagnosis is made due to an incidental finding.
Only a minority presents with clinical signs of jaundice/obstruction, cholangitis/pancreatitis, or an acute abdomen due to secondary complications.
Recently, prenatal ultrasound diagnosis was reported.
What are the possible complications of choledochal cysts?
Choledocholithiasis and hepatolithiasis, leading to bile duct obstruction, jaundice, cholangitis, cholecystitis, pancreatic reflux and pancreatitis, and sepsis.
Ascending cholangitis is a suspected carcinogen for malignant transformation of the cyst.
Cyst rupture and peritonitis are rare complications of choledochal cysts.
How does the diagnostic workup for suspected choledochal cyst look like?
The diagnostic workup includes serologic markers for inflammation, cholestasis as well as imaging by sonography, CT scan, hepatobiliary scintigraphy with Technetium 99 (HIDA), MRCP, or ERCP (Figs. 37.1 and 37.2).
Apart from an abdominal ultrasound, imaging in the typical age group of the patients has the disadvantage of a general anesthesia or sedation.
In large centers an abdominal ultrasound is the only preoperative imaging needed.
An MRCP can be added in unclear cases.
ERCP and potential stenting are mainly reserved for patients with acute biliary obstruction.
What is the most common complication following ERCPs?
Acute pancreatitis, which occurs in approximately 5% of cases after ERCP.
Less common complications include bleeding after sphincterotomy, duodenal perforation, and retroperitoneal abscesses.
What is the treatment of choledochal cysts?
Surgery with complete cyst excision.
Based on preoperative imaging and classification, this may include cyst excision and hepatic resections.
In rare cases with involvement of the pancreatic duct, a Whipple procedure needs to be considered.
What is the best timing of surgery?
Shortly after diagnosis, from three months of age onwards. If diagnosed during an inflammatory episode, broad-spectrum antibiotics should be given first followed by surgery after an inflammatory-free interval of 6–8 weeks.
What is the major risk if a child with choledochal cyst is left untreated?
Patients with untreated choledochal cysts have an increased risk of cholangiocarcinoma and gallbladder carcinoma.
While cases of malignant transformation during childhood are extremely rare, the lifetime carcinoma risk in adults with untreated choledochal cysts is 6–30%, increasing with age.
Furthermore, patients have a high risk of hepatolithiasis, recurrent cholangitis, and pancreatitis.
What is Caroli’s disease and how is it treated?
Caroli’s disease is a rare congenital condition with non-obstructive dilatation of the intrahepatic ducts, which can be localized in one hepatic lobe or disseminated all over the intrahepatic bile ducts.
Based on the localization an (extended) hepatectomy in unilateral appearance and liver transplantation in bilateral, disseminated cases have been described [Lee HK, et al. (2009), Korean J Radiol., Jan–Feb; 10(1):71–80].
What are surgical approaches to choledochal cyst excision?
Choledochal cyst excisions can be performed by laparotomy or laparoscopy [2].
Based on the current literature, none of the approaches is superior.
However, recent studies suggest that children undergoing laparoscopic cyst excision have longer operating times, less intraoperative bleeding (and blood transfusions), shorter hospital stay, and faster recovery.
Is complete cyst excision always feasible?
Any operation should always aim to excise the cyst completely.
However, in some cases the cyst can expand into the porta hepatis, the head of the pancreas, or the duodenum.
The extent of the resection then needs to be determined by the surgeon as remnants of the cyst predispose to malignancies.
Furthermore, in patients with recurrent inflammation prior to surgery, the cyst can be adherent the fragile tissues surrounding it.
In these cases, the risk of vascular injury is increased.
Whenever the decision for incomplete cyst excision is made, the surgeon should resect as much of the biliary epithelium as possible.
Which anatomic reconstructions are performed following cyst excision?
Hepatico-jejunostomy with a Roux-en-Y loop or hepatico-duodenostomy.
Based on the lack of comparative studies in the current literature, none of the techniques is superior [3, 4].
However, recent studies suggest that while the frequency of postoperative bile leaks and anastomotic strictures are equivalent using both techniques, the rates of cholangitis and biliary reflux are higher following hepatico-duodenostomy.
Cholecystectomy is always part of the operation.
Is there any indication for cysto-enteric drainage?
No. While cysto-enteric drainage was performed in the past, a complete cyst excision needs to be achieved according to the current consensus.
What are the intraoperative complications of choledochal cyst excisions?
Major intraoperative complications include bleeding, intraoperative cyst perforation, and narrowing of the pancreatic duct.
Furthermore, all surrounding tissue/ organs—especially the hepatoduodenal ligament should be handled with great caution.
What are postoperative complications following choledochal cyst
excisions?
The most important postoperative complication is a bile leak or stricture of the bil- iodigestive anastomosis with recurrent episodes of cholangitis.
In addition, post- operative anastomotic leaks of enteric anastomosis, fluid collections (hematoma, biloma, abscess), peritonitis, sepsis, bleedings, hepatolithiasis, biliary reflux, and pancreatitis can occur [5].
Is there a potential postoperative risk of malignancies?
After choledochal cyst excision the lifetime risk for malignancies is reduced significantly.
However, recent data suggest a lifelong elevated risk of up to 11% of a local malignancy even following operation [6].
Are postoperative follow-ups necessary?
Due to the persistent risk of malignancies, even following cyst excision, life- long follow-ups are necessary including transition to adult gastroenterology.
For adults, a yearly abdominal ultrasound including measurement of CA19-9 are recommended.
Discuss pediatric gallbladder disease.
Pediatric gallstone disease is on the rise in the United States, for two main reasons.
First, improved diagnostic tools including high-resolution ultrasound have made the detection of small stones more readily apparent.
Secondly, dietary changes have led to an increased incidence of cholesterol stones.
Additionally, improved survival in the neonatal population, many of whom are maintained on parenteral nutrition for an extended period of time, has led to pathophysiology previously seen in very limited instances.
Laparoscopic cholecystectomy remains the standard operation of choice for patients requiring surgical extirpation of the gallbladder alone.
Regional variation in expertise dictates the management of choledocholithiasis using either laparoscopic common bile duct exploration or endoscopic retrograde cholangiopancreatography.